You are here: Industry Insights > COVID-19 Vaccine

News List

Sinovac begins Covid-19 vaccine candidate trials in Turkey pharmaceutical-business-review
September 27, 2020
Chinese biopharmaceutical company Sinovac Biotech has begun phase III clinical trials for its inactivated Covid-19 vaccine candidate in Turkey.
Novavax begins late-stage trial of COVID-19 vaccine in the UK expresspharma
September 27, 2020
Data from the trial - likely over the next four to six weeks - will support regulatory submissions for license in the UK, EU and other countries.
J&J COVID-19 vaccine candidate yields strong immune response in early trial expresspharma
September 27, 2020
Immune response results were available from only 15 people over 65 years old, limiting the interpretation.
EU to receive 300 million COVID-19 vaccine doses from Sanofi and GSK europeanpharmaceuticalreview
September 27, 2020
A contract for 300 doses of the investigational COVID-19 vaccine candidate has been signed by the European Commission (EC).
Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK expresspharma
September 24, 2020
This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.
Pfizer and BioNTech submit proposal to US FDA to expand COVID-19 vaccine trial expresspharma
September 24, 2020
The companies expect that a conclusive readout on efficacy is likely by the end of October.
Sinovac reports preliminary Phase I/II results of COVID-19 vaccine in elderly volunteers worldpharmanews
September 24, 2020
Sinovac Biotech Ltd. ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences (Sinovac LS), or "CoronaVac,"shows good safety ...
Sanofi and GSK sign Covid-19 vaccine supply deal with Canada pharmaceutical-technology
September 24, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a deal with the Government of Canada to supply up to 72 million doses of adjuvanted Covid-19 vaccine candidate from next year.
Bharat Biotech signs deal with Washington University School of Medicine in St Louis for COVID-19 vaccine expresspharma
September 24, 2020
Bharat Biotech owns the rights to distribute the chimp-adenovirus, single-dose intranasal vaccine candidate in all markets except the US, Japan and Europe.
Russia to supply Mexico with 32 million doses of Sputnik V europeanpharmaceuticalreview
September 24, 2020
The Russian Direct Investment Fund (RDIF) said the supply of the COVID-19 vaccine should enable 25 percent of the population to be vaccinated.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page